Arginase inhibition alleviates hypertension in the metabolic syndrome.
about
Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-AtherosclerosisArginase promotes endothelial dysfunction and hypertension in obese ratsNeonatal Citrulline Supplementation and Later Exposure to a High Fructose Diet in Rats Born with a Low Birth Weight: A Preliminary ReportControl of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.Xanthine oxidase inhibition alleviates the cardiac complications of insulin resistance: effect on low grade inflammation and the angiotensin system.Phenolics from Garcinia mangostana alleviate exaggerated vasoconstriction in metabolic syndrome through direct vasodilatation and nitric oxide generation.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Alterations in Circulating Amino Acid Metabolite Ratio Associated with Arginase Activity Are Potential Indicators of Metabolic Syndrome: The Korean Genome and Epidemiology Study.Citrulline and Nonessential Amino Acids Prevent Fructose-Induced Nonalcoholic Fatty Liver Disease in Rats.Effects of a pre-workout supplement on hyperemia following leg extension resistance exercise to failure with different resistance loads.Arginine methylation dysfunction increased risk of acute coronary syndrome in coronary artery disease population: A case-control study.Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.Characterization of vascular complications in experimental model of fructose-induced metabolic syndrome.Zingerone alleviates the delayed ventricular repolarization and AV conduction in diabetes: Effect on cardiac fibrosis and inflammation.Amentoflavone improves cardiovascular dysfunction and metabolic abnormalities in high fructose and fat diet-fed rats.Arginase inhibition prevents the development of hypertension and improves insulin resistance in obese rats.Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.
P2860
Q26991946-DEDFD434-6B31-4665-BB8B-96045F4E3798Q28386943-5318E594-AB67-4108-A320-934EDE83544DQ33616820-B7C8F097-FCE7-4CE2-A61A-213FD4617EBEQ34507936-FEA56306-9522-4D3D-B97C-B68704477841Q35166562-BE407E46-FE9E-444C-B3CE-93E6E26D52EBQ36130309-5DC1129C-CAFE-4C6B-ABB1-84E7D572D54EQ37102697-17938089-C874-4259-97FD-26B18553FF1AQ38401121-866E541D-04FA-4768-BB08-5E5FCC969FB3Q40656080-26AC7538-D424-4F8E-A4A5-F7621BC73FB7Q41675059-A90002AB-3471-4172-B322-D85BFC7FF068Q42040317-96152C42-AE67-4345-A675-492F9C0A0078Q42704340-02E77002-2666-40E6-9C1A-5EED3DC318D4Q46863764-6B468134-8296-4D97-A7FE-75F1FDAE84B4Q47144195-49CC2DE4-1182-423D-B724-61F0124ABBFDQ47423975-CD5B08D9-31CB-4F37-A791-5B046CEEB358Q53691008-4E933BFB-4AED-4695-A6A6-80D5FD9DDDBCQ53798961-17A06CFC-414D-4C77-A831-A6BEA67CF55DQ53817773-B3506A84-3058-4BE0-9B3D-78E7FC82A7E6
P2860
Arginase inhibition alleviates hypertension in the metabolic syndrome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Arginase inhibition alleviates hypertension in the metabolic syndrome.
@en
type
label
Arginase inhibition alleviates hypertension in the metabolic syndrome.
@en
prefLabel
Arginase inhibition alleviates hypertension in the metabolic syndrome.
@en
P2093
P2860
P356
P1476
Arginase inhibition alleviates hypertension in the metabolic syndrome.
@en
P2093
Ahmed Fahmy
Hany M El-Bassossy
Malcolm L Watson
Rania El-Fawal
P2860
P304
P356
10.1111/BPH.12144
P407
P577
2013-06-01T00:00:00Z